Neuroscience

An international study was launched when researchers found that another inhibitor for advanced cancers, called OTS167, had a negative outcome in a clinical trial
| 4 min read

An international study was launched when researchers found that another inhibitor for advanced cancers, called OTS167, had a negative outcome in a clinical trial